A detailed history of Narus Financial Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Narus Financial Partners, LLC holds 716 shares of AMGN stock, worth $203,064. This represents 0.08% of its overall portfolio holdings.

Number of Shares
716
Previous 716 -0.0%
Holding current value
$203,064
Previous $224 Million 3.12%
% of portfolio
0.08%
Previous 0.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 25, 2024

SELL
$255.7 - $288.46 $15,342 - $17,307
-60 Reduced 7.73%
716 $206 Million
Q3 2023

Oct 30, 2023

BUY
$218.65 - $271.46 $169,672 - $210,652
776 New
776 $209 Million
Q4 2022

Oct 12, 2023

BUY
$229.03 - $291.01 $181,620 - $230,770
793 New
793 $208 Million
Q1 2021

Mar 07, 2024

BUY
$221.91 - $258.6 $31,955 - $37,238
144 Added 20.11%
860 $214 Million
Q4 2019

May 14, 2024

BUY
$189.21 - $243.2 $27,246 - $35,020
144 Added 20.11%
860 $207 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $152B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Narus Financial Partners, LLC Portfolio

Follow Narus Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Narus Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Narus Financial Partners, LLC with notifications on news.